New Drugs

Brand/Generic Company Description
Biktarvy
bictegravir/ emtricitabine/tenofovir alafenamide
Click here for more information
Gilead Sciences

A combination drug for treatment of HIV-1 infection.

Erleada
apalutamide
Click here for more information
Janssen

An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer.

Ilumya
tildrakizumab-asmn
Click here for more information
Merck

An interleukin-23 antagonist for moderate-to-severe plaque psoriasis.

Lutathera
lutetium Lu 177 dotatate
Click here for more information
Advanced Accelerator Applic.

A radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors.

Symdeko
tezacaftor/ivacaftor
Click here for more information
Vertex Pharm.

A combination formulation for cystic fibrosis in patients with a specific gene mutation.

Trogarzo
ibalizumab-uiyk
Click here for more information
Thera Technologies

An antiretroviral for patients with multidrug resistant HIV-1 infection.

Brand/Generic Company Description
Apadaz
benzhydrocodone/acetaminophen
Click here for more information
KemPharm

New combination formulation for short-term management of acute pain.

Cimduo
lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Dexycu
dexamethasone
Click here for more information
Icon Bioscience

New intraocular suspension formulation for postoperative inflammation.

Firvanq
vancomycin
CurtisPharma

An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA).

Osmolex ER
amantadine
Click here for more information
Vertical Pharm.

New extended-release tablet formulation.

Symfi
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection. Contains a higher strength of efavirenz/tablet vs Symfi Lo.

Symfi Lo
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Ztlido
lidocaine
Click here for more information
Scilex Pharm.

New topical patch formulation for post-herpetic neuralgia pain.

Brand/Generic Company Description
Zinbryta
Daclizumab
Click here for more information
Biogen/AbbVie

The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions.